BioPharma

16 September, 2026 | Wednesday | News

Ecolab Life Sciences Opens New Resin Manufacturing Facility in China

Demand for advanced purification solutions is growing as industries look to improve performance while using less water and fewer natural resources. Industries are increasingly turning to advanced separation, pu...

Lab

16 September, 2026 | Wednesday | News

Thermo Fisher Scientific Launches 250-Litre Heratherm Environmental Chambers for Stability Testing and Quality Control

Thermo Fisher Scientific has introduced the Thermo Scientific™ Heratherm™ Environmental Chambers with a 250-litre capacity, expanding its environmental chamber portfolio with a compact, stackable so...

BioTech

16 September, 2026 | Wednesday | News

Single Cell Discoveries Acquires TATAA Biocenter to Build Integrated Discovery-to-Validation CRO

Single Cell Discoveries (SCD), a specialist contract research organization (CRO) focused on discovery transcriptomics, has completed the acquisition of TATAA Biocenter, a globally recognized leader in qPCR, bio...

Contract Services

16 September, 2026 | Wednesday | News

Single Cell Discoveries Acquires TATAA Biocenter to Build Integrated Discovery-to-Validation CRO

Single Cell Discoveries (SCD), a specialist contract research organization (CRO) focused on discovery transcriptomics, has completed the acquisition of TATAA Biocenter, a globally recognized leader in qPCR, bio...

Consumer Health

10 September, 2026 | Thursday | News

Kelun-Biotech’s Twice-Yearly Asthma Candidate SKB378 Advances into Phase III

The POLARIS-1 study enrolled 147 patients with uncontrolled, moderate-to-severe asthma, and the interim analysis was conducted on the first 98 patients. The analysis demonstrated a half-life of up to 75 days,...

Medtech

16 September, 2026 | Wednesday | News

Ferronova’s Nanoparticle Platform Shows Promise for More Precise Gastric and Oesophageal Cancer Surgery

Australian medical technology company Ferronova has announced preliminary findings from the MAGMAP multi-centre trial involving 62 gastric and oesophageal patients evaluating the safety and feasibility of ...

Cell & Gene

04 September, 2026 | Friday | News

Alteogen, Novartis Ink Up to $3.2B Deal for Subcutaneous Biologics Using ALT-B4

Novartis obtains rights to develop and commercialize subcutaneous formulations for multiple products utilizing ALT-B4 Alteogen's fourth licensing agreement signed this year further accelerating the expansion...


White Paper

09 September, 2026 | Wednesday | Analysis

The Arbitrage Triangle

Premium Article

Biopharma APAC Infomercial

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close